Căutare | BURSA.RO

The European deputy stated that in these moments the patient is no longer a normal citizen, but only a patient because the pharma industry has turned him into a patient through the adverse effects of some drugs or by performing some tests.

Gheorghe Piperea: "Bill Gates has already announced that we must prepare for a new pandemic; that means the pharma industry already has the vaccines"

The appearance of new diseases simultaneously with the appearance of new vaccines and medicines is proof that the pharma industry is involved in turning citizens into simple patients, claims European deputy Gheorghe Piperea, lawyer and university...

There are voices that claim that some diseases are artificially created, while at the same time their related remedies are launched. (illustration: collage by MAKE)

Artificially created diseases; examples (II)

• b) Metabolic syndrome - one of the invented diseases

Based on a well-crafted strategy aimed at artificially expanding the market, the pharma giants seem to have become experts in "disease-making" and exaggerating common symptomatology in order to turn healthy people into drug-dependent patients. , a practice whose consequences are serious for public health and for the trust that patients have in the medical system.

Artificially created diseases; examples (I)

The modern pharmaceutical industry, a global market of billions of dollars, is no longer limited to treating and curing the sick. In recent years, new advertising techniques have been developed that aggressively target healthy audiences, turning...

Renate Weber on the turf of the PSD - The ombudsman

Renate Weber is to the Ombudsman what Valer Dorneanu is to the Constitutional Court: a political representative, heavily anchored in the past, who, instead of reforming the institution they are in charge of, has turned it into a tool they use as...

Statul New York acuză Johnson & Johnson de fraudă cu asigurări, pentru că a minimalizat riscul opioidelor

Statul New York a înregistrat joi un proces civil împotriva grupului Johnson & Johnson, pe care îl acuză de fraudă cu asigurări pentru că a minimalizat riscurile analgezicelor pe bază de opiu, inclusiv pentru medici şi pacienţii vârstnici,...

Why do pharma companies need immunity against the law?

The authorities and pharma companies are not even trying to hide the fact that they see the population as anything more than a mob of guinea pigs without any rights.

SUA:Grupul Johnson & Johnson a fost amendat pentru facilitatea crizei opioidelor

Grupul Johnson & Johnson a fost amendat marţi cu 572,1 milioane de dolari pentru facilitarea crizei opioidelor din Statele Unite, fiind găsit responsabil de un judecător din Oklahoma. Suma este mult mai mică decât anticipau analiştii, astfel...

BURSELE DIN LUMEBursele europene urcă după ce populiştii italieni au lansat o propunere de prim-ministru

Acţiunile companiilor listate la bursele din Europa au urmat un curs pozitiv ieri, după ce Giuseppe Conte a fost propus prim-ministru în Italia de coaliţia populistă formată din Mişcarea 5 Stele şi Liga.

Radu Răşinar, noul preşedinte al Local American Working Group

Radu Răşinar, Director General AstraZeneca pentru Europa de Sud-Est, a fost ales noul preşedinte al asociaţiei Local American Working Group.

Noul preşedinte al ARPIM este şeful Bristol-Myers Squibb România

Călin Gălăşeanu, country manager în cadrul companiei Bristol-Myers Squibb (BMS), a fost ales preşedinte al Asociaţiei Române a Producătorilor Internaţionali de Medicamente (ARPIM), conform unui comunicat de presă.

MSD intends to bring new products on the Romanian pharmaceutical market

Reporter: First of all, what are your plans after taking over the management of the company?

Profitul "Actavis" nu va depăşi 10% din cifra de afaceri, în 2011

• (Interviu cu doamna Alina Culcea, director general "Actavis" România, şi domnul Bogdan Oghină, director general al fabricii "Sindan Pharma")

Secom, cifră de afaceri în creştere cu 100% în primul semestru

Secom, firmă ce activează pe piaţa de parafarmaceutice, şi-a dublat cifra de afaceri în primul semestru al anului în curs, comparativ cu aceeaşi perioadă din 2008, la 1, 3 milioane de euro. "Compania, care şi-a targetat o creştere de 100% a...

Valerie Ansart, Urgo International Marketing Manager(left), şi Anne Durocher, Urgo Country Manager for România

ESTIMATES FOR 2009Romanian sales of Laboratoires Urgo expected to increase almost 10% this year

Cornelia Angelescu

Zentiva Sees 21.3% Higher Sales in H1

Zenitva Group posted total net sales of 6,796.6 million CZK, up 5.5% from 6,441.2 million CZK in the first half of 2006. This increase in sales was the result of an 8.7% increase in pharmaceutical sales.

Gedeon Richter Inaugurates 9 Mln USD Logistics Centre

Gedeon Richter Romania on Tuesday inaugurated its pharmaceutical logistics centre located in Corunca, Mures County. The construction work started in 6006 as part of the company"s expansion plan. The investment amounted to 9 million USD....

A&D Pharma Turnover Up 34%

A&D Pharma Holdings SRL posted 331,6 million EUR in turnover for 2006, up 34% year-on-year. EBITDA reached 28,1 million EUR, up 12% compared to 2005, while net profit amounted 17,8 million EUR, incresing by 7,4% year-on-year.

"Antibiotice" aşteaptă investitorii strategici

Acţiunile deţinute de stat la "Antibiotice" Iaşi vor fi vîndute conform planului de privatizare demarat de Autoritatea pentru Valorificarea Activelor Statului, iar astăzi este ultima zi în care a mai fost posibilă depunerea ofertelor...

"Iassyfarm" şi-a dublat profitul anul trecut

Cu toate că anul trecut compania "Iassyfarm" şi-a dublat profitul net, ea s-a confruntat şi cu o serie de probleme specifice sectorului în care activează, probleme care continuă şi în acest an. Alin Rădăşanu, directorul financiar al...